EcoDrugPlus

V-Akt Murine Thymoma Viral Oncogene Homolog 1

Ensembl ID : ENSSMAG00000006661
Gene Symbol: AKT1
2 Cross references
195 Possible Orthologues:

V-Akt Murine Thymoma Viral Oncogene Homolog 2

Ensembl ID : ENSSMAG00000001137
Gene Symbol: AKT2
3 Cross references
209 Possible Orthologues:

V-Akt Murine Thymoma Viral Oncogene Homolog 3a

Ensembl ID : ENSSMAG00000018047
Gene Symbol: AKT3A
3 Cross references
203 Possible Orthologues:

V-Rel Avian Reticuloendotheliosis Viral Oncogene Homolog A

Ensembl ID : ENSSMAG00000014895
Gene Symbol: RELA
3 Cross references
199 Possible Orthologues:

V-Src Avian Sarcoma (Schmidt-Ruppin A-2) Viral Oncogene Homolog

Ensembl ID : ENSSMAG00000019082
Gene Symbol: SRC
3 Cross references
197 Possible Orthologues:

Vascular Endothelial Growth Factor A-A-Like

Ensembl ID : ENSSMAG00000013558
Gene Symbol: LOC118284804
2 Cross references
181 Possible Orthologues:

Vascular Endothelial Growth Factor Ab

Ensembl ID : ENSSMAG00000009385
Gene Symbol: VEGFAB
3 Cross references
201 Possible Orthologues:

Vitamin D3 Receptor A

Ensembl ID : ENSSMAG00000006291
Gene Symbol: LOC118316740
2 Cross references
388 Possible Orthologues:

Vitamin D3 Receptor B

Ensembl ID : ENSSMAG00000007590
Gene Symbol: LOC118308731
3 Cross references
392 Possible Orthologues:

Vitamin K Epoxide Reductase Complex, Subunit 1

Ensembl ID : ENSSMAG00000016474
Gene Symbol: VKORC1
3 Cross references
190 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Beta-4-Like

Ensembl ID : ENSSMAG00000012768
Gene Symbol: LOC118300716
2 Cross references
69 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-4 Subunit-Like

Ensembl ID : ENSSMAG00000012239
Gene Symbol: LOC118292315
3 Cross references
167 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).